Immunovant, Inc. (IMVT) Earnings
NASDAQ·Healthcare·Biotechnology
$27.39
-4.30%
Mkt Cap $6.00B
Next Earnings
In 28 daysWed, May 27, 2026
EPS Estimate
-$2.57
10 analysts
Revenue Estimate
$6.64M
Last quarter: beat by +15.28% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$6.00B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.69